Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries

Journal of Trauma - Injury, Infection and Critical Care

Volumn 46, Issue 2, 1999, Pages 297-305

  Brown, Glenn E ^a,c   Silver, Geoffrey M ^a   Reiff, Joel ^a   Allen, Robert C ^b   Fink, Mitchell P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Division of iVitalize   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Base deficit; Chemiluminescence; CR3; Injury Severity Score; Leukotriene B4; Platelet activating factor; Polymorphonuclear neutrophil; Priming; Tumor necrosis factor

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3; LEUKOTRIENE B4; RECOMBINANT INTERLEUKIN 8; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BLOOD SAMPLING; BLUNT TRAUMA; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPLEMENT SYSTEM; CONFERENCE PAPER; HUMAN; HUMAN CELL; INJURY SCALE; INTENSIVE CARE UNIT; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0032995365     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199902000-00017     Document Type: Conference Paper

References (45)

1. Christou NV, Meakins JL. Neutrophil function in anergic surgical patients: neutrophil adherence and chemotaxis. Ann Surg. 1979;190:557-564.
2. Maderazo EG, Albano SD, Woronick CL, et al. Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients. Ann Surg. 1983;198:736.
3. Alexander JW, Hegg M, Altemeier WA. Neutrophil function in selected surgical disorders. Ann Surg. 1968;168:447-458.
4. Sweeney JF, Rosemurgy AS, Wei S, Djeu JY. Impaired polymorphonuclear leukocyte anticandidal function in injured adults with elevated Candida antigen titers. Arch Surg. 1993;128:40-45.
5. Maderazo EG, Woronick CL, Albano SD, et al. Inappropriate activation, deactivation, and probable autooxidative damage as a mechanism of neutrophil locomotory defect in trauma. J Infect Dis. 1986;154:471.
6. Tanaka H, Ogura H, Yokota J, et al. Acceleration of superoxide production from leukocytes in trauma patients. Ann Surg. 1991;214:187.
7. Cottage S, Takaku F, Sakamoto S. A comparison of the superoxide-releasing response in human polymorphonuclear leukocytes and monocytes. J Immunol. 1980;125:359.
8. Van Epps DE, Garcia ML. Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J Clin Invest. 1980;66:167.
9. Beswick PH, Kay AB. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils. Clin Exp Immunol. 1981;43:399.
10. English D, Roloff JS, Lukens JN. Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils. Blood. 1981;58:129.
11. Brown, GE, Reiff, R, Allen RC, Silver GM, Fink MP. Maintenance and down-regulation of primed neutrophil chemiluminescence activity in human whole blood. J Leukocyte Biol 1997;62:837.
12. Badwey JA, Karnovsky ML. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem. 1980;49:695.
13. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365.
14. Berger M, O'Shea J, Cross AS, et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest. 1984;74:1566.
15. Arnaout MA, Spits H, Terhorst C, et al. Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with MO1 deficiency: effects of cell activation on Mol/LAF-1 surface expression in normal and deficient leukocytes. J Clin Invest. 1984;74:1291.
16. Glasser L, Fiederlein RL. The effect of various cell separation procedures on assays of neutrophil function. Am J Clin Pathol. 1990;93:662.
17. Nathan CF. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest. 1987;80:1550.
18. Yuo A, Kitagawa S, Kasahara T, et al. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood. 1991;78:2708.
19. Gay JC, Beckman JK, Brash AR, Oates JA, Lukens JN. Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4. Blood. 1984; 64:780.
20. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 1986;133:449.
21. Stevens DL, Bryant AE, Huffman J, et al. Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J Infect Dis. 1994;170:1463.
22. Allen RC. Role of oxygen in phagocyte microbicidal action. Environ Health Perspect. 1994;102:201.
23. Brown GE, Reed EB, Lanser ME. Neutrophil CR3 expression and specific granule exocytosis are controlled by different signal transduction pathways. J Immunol. 1991; 147:965.
24. Allen RC, Stevens DL. The circulating phagocyte reflects the in vivo state of immune defense. Curr Opin Infect Dis. 1992;5:389.
25. Baggiolini M, DeWald B. Stimulus amplification by PAF and LTB4 in human neutrophils. Pharmacol Res Commun Suppl. 1986;18:51.
26. Worthen GS, Seccombe JF, Clay KL, et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor: potential role in mediation of enhanced superoxide secretion. J Immunol. 1988;140:3553.
27. Botha AJ, Moore FA, Moore EE. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med. 1994;22:894.
28. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016.
29. Rivkind AI, Siegel JH, Guadalupi P, et al. Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. Ann Surg. 1989;210:355.
30. Moore FD Jr, Davis C, Rodrick M, et al. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med. 1986; 314:948.
31. Nelson RD, Hasslen SR, Ahrenholz DR, et al. Influence of minor thermal injury on expression of complement receptor CR3 on human neutrophils. Am J Pathol. 1986;125:563.
32. Lin RY, Astiz ME, Saxon JC, et al. Altered leukocyte immunophenotypes in septic shock: studies of HLA-DR, CD11b, CD14, and IL2R expression. Chest. 1993;104:847.
33. Scannell G, Waxman K, Vaziri ND, et al. Effects of trauma on leukocyte intracellular adhesion molecule-a, CD11b, and CD18 expressions. J Trauma. 1995;39:641.
34. Solomkin JS, Cotta LA, Brodt JK, et al. Regulation of neutrophil superoxide production in sepsis. Arch Surg. 1985; 120:93.
35. Shaked G, Alkan M, Nagauker O, et al. Superoxide production by neutrophils from trauma patients: regulation of NADPH oxidase activity. J Trauma. 1994;37:22.
36. Rivkind AI, Siegel JH, Littleton M, et al. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock. 1991;33:48.
37. Solomkin JS, Cotta LA, Ogle JD, et al. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma. Surgery. 1984;96:336.
38. Browder W, Williams D, Pretus H, et al. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg. 1990;21:605.
39. Botha AJ, Moore FA, Moore EE, et al. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery. 1995;118:358.
40. Lanser ME, Mao P, Brown G, et al. Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg. 1985;202:111.
41. Lanser ME, Mao P, Brown GE, et al. Neutrophil chemiluminescence and opsonic fibronectin levels following blunt trauma. J Surg Res. 1986;41:264.
42. Lanser ME, Brown GE, Mora R, et al. Trauma serum suppresses superoxide production by normal neutrophils. Arch Surg. 1986;121:157.
43. Vassar MJ, Fletcher MP, Perry CA, et al. Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: a prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation. Prostaglandins Leukotrienes Essent Fatty Acids. 1991;44:223.
44. Linke RP, Bock V, Valet G, et al. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun. 1991;176:1100.
45. Dobrinich R, Spagnuolo PJ. Binding of C-reactive protein to human neutrophils: inhibition of respiratory burst activity. Arthritis Rheum. 1991;34:1031.